Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

BRONKOSOL

ISOETHARINE HYDROCHLORIDE

Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BRONKOSOL is listed in Drugs@FDA under application 012339 (NDA).

Marketing status: Discontinued Active ingredient ISOETHARINE HYDROCHLORIDE Form and strength SOLUTION;INHALATION - 1% Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BRONKOSOL is listed in Drugs@FDA under application 012339 (NDA). Marketing status: Discontinued Active ingredient ISOETHARINE HYDROCHLORIDE Form and strength SOLUTION;INHALATION - 1% Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.